Patient-Specific Stem Cells

Nonfiction, Health & Well Being, Medical, Medical Science, Biotechnology, Science & Nature, Science, Biological Sciences
Cover of the book Patient-Specific Stem Cells by , CRC Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781315402161
Publisher: CRC Press Publication: April 7, 2017
Imprint: CRC Press Language: English
Author:
ISBN: 9781315402161
Publisher: CRC Press
Publication: April 7, 2017
Imprint: CRC Press
Language: English

One of the biggest challenges faced in medical research had been to create accurate and relevant models of human disease. A number of good animal models have been developed to understand the pathophysiology. However, not all of them reflect the human disorder, a classic case being Usher’s syndrome where the mutant mice do not have the same visual and auditory defects that patients face. There are others which have been even more difficult to model due to the multi-factorial nature of the condition and due to lack of discovery of a single causative gene such as age-related macular degeneration or Alzheimer’s syndrome. Thus a more relevant and accurate system will allow us to make better predictions on relevant therapeutic approaches.

The discovery of human pluripotent stem cells in 1998 followed by the technological advances to reprogram somatic cells to pluripotent-stem cell-like cells in 2006 has completely revolutionized the way we can now think about modelling human development and disease. This now coupled with genome editing technologies such as TALENS and CRISPRs have now set us up to develop in vitro models both 2D as well as 3D organoids, which can more precisely reflect the disease in the patients. These combinatorial technologies are already providing us with better tools and therapeutics in drug discovery or gene therapy.

This book summarizes both the technological advances in the field of generation of patient specific lines as well as various gene editing approaches followed by its applicability in various systems. The book will serve as a reference for the current state of the field as it:

-Provides a comprehensive overview of the status of the field of patients derived induced pluripotent stem cells.

-Describes the use of cardiac cells as a main featured component within the book.

-Examines drug toxicity analysis as a working example throughout the book.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

One of the biggest challenges faced in medical research had been to create accurate and relevant models of human disease. A number of good animal models have been developed to understand the pathophysiology. However, not all of them reflect the human disorder, a classic case being Usher’s syndrome where the mutant mice do not have the same visual and auditory defects that patients face. There are others which have been even more difficult to model due to the multi-factorial nature of the condition and due to lack of discovery of a single causative gene such as age-related macular degeneration or Alzheimer’s syndrome. Thus a more relevant and accurate system will allow us to make better predictions on relevant therapeutic approaches.

The discovery of human pluripotent stem cells in 1998 followed by the technological advances to reprogram somatic cells to pluripotent-stem cell-like cells in 2006 has completely revolutionized the way we can now think about modelling human development and disease. This now coupled with genome editing technologies such as TALENS and CRISPRs have now set us up to develop in vitro models both 2D as well as 3D organoids, which can more precisely reflect the disease in the patients. These combinatorial technologies are already providing us with better tools and therapeutics in drug discovery or gene therapy.

This book summarizes both the technological advances in the field of generation of patient specific lines as well as various gene editing approaches followed by its applicability in various systems. The book will serve as a reference for the current state of the field as it:

-Provides a comprehensive overview of the status of the field of patients derived induced pluripotent stem cells.

-Describes the use of cardiac cells as a main featured component within the book.

-Examines drug toxicity analysis as a working example throughout the book.

More books from CRC Press

Cover of the book Sensors for Diagnostics and Monitoring by
Cover of the book Poverty and Child Health by
Cover of the book The Journey to Dissertation Success by
Cover of the book How Safe is Safe Enough? by
Cover of the book Basic Statistics and Epidemiology by
Cover of the book Linear and Switch-Mode RF Power Amplifiers by
Cover of the book Simulation Methodology for Statisticians, Operations Analysts, and Engineers (1988) by
Cover of the book Structural Building Design by
Cover of the book Clinical Signs in Small Animal Medicine by
Cover of the book Handbook of Discrete and Combinatorial Mathematics by
Cover of the book Quality in General Practice by
Cover of the book Heavy Ion Reactions by
Cover of the book Cadmium in the Environment by
Cover of the book Ophthalmology Fact Fixer by
Cover of the book Manufactured Gas Plant Remediation by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy